Business
Tandem Diabetes Care Announces Upcoming Virtual Conference Presentation
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today announced that

About this update from Tandem Diabetes Care, Inc.
[{"type":"text","content":" SAN DIEGO--(BUSINESS WIRE)--\nTandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today announced that management will present a company update at the Piper Sandler Virtual Diabetes Symposium on Wednesday, May 25, 2022 at 11:00am Eastern Time (8:00am Pacific Time).\n\nThe Company update presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.\n\nAbout Tandem Diabetes Care, Inc.\n\nTandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit tandemdiabetes.com.\n\nTandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.\n\nFollow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, and $TNDM.\nFollow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.\nFollow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20220518005778/en/\n\nMedia Contact:\nSteve Sabicer\n714-907-6264\[email protected]\n\nInvestor Contact:\nSusan Morrison\n858-366-6900\[email protected]\n\nSource: Tandem Diabetes Care, Inc.","length":4507,"tagName":"div"}]